
West Pharmaceutical Services, Inc.
WSTNYSEHealthcareMedical - Instruments & Supplies
Previous close
$353.08
−$0.69 · -0.20%
WST company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
49
Fair Value
Momentum
57
Neutral
Sentiment
70
Bullish
Risk resilience
77
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteWest Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Eric Green
- Listed since
- Mar 17, 1980
- Employees
- 10,800
Market position
Day range
Current $353.08
52-week range
Current $353.08
- Open
- $356.88
- Previous close
- $353.77
- Volume
- 424.73K
- 0.53× average
- Average volume
- 804.13K
- Average daily volume
- Market cap
- 24.85B USD
- Beta
- 1.14
- Market reference 1
- 50-day average
- $347.81
- +1.52% above average
- 200-day average
- $290.2
- +21.67% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 19.52B USD
- P/E (TTM)
- 44.86×
- P/B (TTM)
- 8.36×
- P/S (TTM)
- 7.47×
- EV / EBITDA
- 26.97×
- Earnings yield
- 2.48%
- Free cash flow yield
- 2.36%
- Dividend yield
- 0.25%
Profitability & efficiency
- Gross margin
- 36.77%
- Operating margin
- 20.64%
- Net margin
- 16.98%
- Return on equity
- 15.54%
- Return on assets
- 11.56%
- Return on invested capital
- 13.62%
Financial health
- Debt / equity
- 0.1×
- Current ratio
- 3.02×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.07B USD | 2.89B USD | 2.95B USD | 2.89B USD | 2.83B USD |
| Cost of goods sold | 1.97B USD | 1.89B USD | 1.82B USD | 1.75B USD | 1.66B USD |
| Gross profit | 1.1B USD | 1B USD | 1.13B USD | 1.14B USD | 1.17B USD |
| Research and development | 74.3M USD | 69.1M USD | 68.4M USD | 58.5M USD | 52.8M USD |
| Selling, general, and administrative | 393.1M USD | 338.5M USD | 353.4M USD | 316.9M USD | 361.9M USD |
| Operating expenses | 485.9M USD | 407.6M USD | 421.8M USD | 375.4M USD | 414.7M USD |
| Interest income | 17.7M USD | 19.6M USD | 28M USD | 5.1M USD | 1M USD |
| Interest expense | 600K USD | 2.9M USD | 8.8M USD | 7.6M USD | 8.5M USD |
| Depreciation and amortization | 124.4M USD | 155.4M USD | 137.3M USD | 120.6M USD | 122.3M USD |
| Operating income | 617.4M USD | 594.6M USD | 710.9M USD | 763.5M USD | 758.7M USD |
| Net income | 493.7M USD | 492.7M USD | 593.4M USD | 585.9M USD | 661.8M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
WST peers
ETFs holding WST
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI767.03M0.03%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO632.29M0.04%1.7T USD0.03%$703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO521.31M0.23%224.7B USD0.03%$82.97+0.53%
iShares Core S&P 500 ETFIVV336.85M0.04%891.84B USD0.03%$769.31+0.39%
Vanguard Morningstar Growth ETFVUG318.48M0.09%372B USD0.03%$87.50+0.38%
State Street SPDR S&P 500 ETFSPY310.85M0.04%817.87B USD0.09%$765.72+0.41%
Invesco S&P 500 Equal Weight ETFRSP200M0.20%100.27B USD0.20%$221.67+0.63%
VanEck Morningstar Wide Moat ETFMOAT189.22M1.53%12.46B USD0.46%$114.42+0.95%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 767.03M
- Weight
- 0.03%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 632.29M
- Weight
- 0.04%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 521.31M
- Weight
- 0.23%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.97+0.53%
iShares Core S&P 500 ETFIVV- Market value
- 336.85M
- Weight
- 0.04%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
Vanguard Morningstar Growth ETFVUG- Market value
- 318.48M
- Weight
- 0.09%
- AUM
- 372B USD
- Expense ratio
- 0.03%
- Price / 1D
- $87.50+0.38%
State Street SPDR S&P 500 ETFSPY- Market value
- 310.85M
- Weight
- 0.04%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Invesco S&P 500 Equal Weight ETFRSP- Market value
- 200M
- Weight
- 0.20%
- AUM
- 100.27B USD
- Expense ratio
- 0.20%
- Price / 1D
- $221.67+0.63%
VanEck Morningstar Wide Moat ETFMOAT- Market value
- 189.22M
- Weight
- 1.53%
- AUM
- 12.46B USD
- Expense ratio
- 0.46%
- Price / 1D
- $114.42+0.95%
Continue in GoAI
Research WSTresearch.disclaimer





